These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 15010695)

  • 1. Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusers.
    Sobel BF; Sigmon SC; Griffiths RR
    Neuropsychopharmacology; 2004 May; 29(5):991-1003. PubMed ID: 15010695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers.
    Jones HE; Griffiths RR
    Psychopharmacology (Berl); 2003 Jan; 165(3):280-90. PubMed ID: 12434259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers.
    Garrett BE; Griffiths RR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):486-94. PubMed ID: 11160635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers.
    Jones HE; Garrett BE; Griffiths RR
    J Pharmacol Exp Ther; 1999 Jan; 288(1):188-97. PubMed ID: 9862770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nicotine withdrawal on panic-like response to breath holding: a placebo-controlled, double-blind, crossover patch study.
    Cosci F; Bertoli G; Abrams K
    Depress Anxiety; 2013 Dec; 30(12):1217-21. PubMed ID: 23554155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
    Cárdenas L; Busto UE; MacDonald A; Corrigall WA
    Can J Clin Pharmacol; 2002; 9(4):175-82. PubMed ID: 12584575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine.
    Donny EC; Jones M
    Drug Alcohol Depend; 2009 Sep; 104(1-2):23-33. PubMed ID: 19446968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cocaine-like subjective effects of nicotine are not blocked by the D1 selective antagonist ecopipam (SCH 39166).
    Chausmer AL; Smith BJ; Kelly RY; Griffiths RR
    Behav Pharmacol; 2003 Mar; 14(2):111-20. PubMed ID: 12658071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral caffeine pretreatment on response to intravenous nicotine and cocaine.
    Johnson MW; Strain EC; Griffiths RR
    Exp Clin Psychopharmacol; 2010 Aug; 18(4):305-15. PubMed ID: 20695686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous caffeine in stimulant drug abusers: subjective reports and physiological effects.
    Rush CR; Sullivan JT; Griffiths RR
    J Pharmacol Exp Ther; 1995 Apr; 273(1):351-8. PubMed ID: 7714788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.
    Rohsenow DJ; Monti PM; Hutchison KE; Swift RM; MacKinnon SV; Sirota AD; Kaplan GB
    Exp Clin Psychopharmacol; 2007 Feb; 15(1):81-92. PubMed ID: 17295587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual-spatial attention in alcoholics and illicit stimulant abusers: effects of nicotine replacement.
    Ceballos NA; Tivis R; Lawton-Craddock A; Nixon SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):97-107. PubMed ID: 15610951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modafinil and nicotine interactions in abstinent smokers.
    Sofuoglu M; Waters AJ; Mooney M
    Hum Psychopharmacol; 2008 Jan; 23(1):21-30. PubMed ID: 17868195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial withdrawal characteristics of nicotine compared with alcohol and caffeine.
    Miyata H; Hironaka N; Takada K; Miyasato K; Nakamura K; Yanagita T
    Ann N Y Acad Sci; 2008 Oct; 1139():458-65. PubMed ID: 18991893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray.
    Myers CS; Taylor RC; Moolchan ET; Heishman SJ
    Neuropsychopharmacology; 2008 Feb; 33(3):588-98. PubMed ID: 17443125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone-nicotine interactions in methadone maintenance treatment patients.
    Elkader AK; Brands B; Selby P; Sproule BA
    J Clin Psychopharmacol; 2009 Jun; 29(3):231-8. PubMed ID: 19440076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers.
    Perkins KA; Lerman C; Keenan J; Fonte C; Coddington S
    Nicotine Tob Res; 2004 Jun; 6(3):501-7. PubMed ID: 15203784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nicotine dose and administration method on withdrawal symptoms and side effects during short-term smoking abstinence.
    Leischow SJ; Valente SN; Hill AL; Otte PS; Aickin M; Holden T; Kligman E; Cook G
    Exp Clin Psychopharmacol; 1997 Feb; 5(1):54-64. PubMed ID: 9234040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine and cognitive efficiency in alcoholics and illicit stimulant abusers: implications of smoking cessation for substance users in treatment.
    Ceballos NA; Tivis R; Lawton-Craddock A; Nixond SJ
    Subst Use Misuse; 2006; 41(3):265-81. PubMed ID: 16467005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.